A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review

Study Identifier
H23-122
CT.gov Identifier
NCT05444972
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Blood Cancer - Other
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Treated for myelofibrosis (MF) \[primary myelofibrosis (PMF) and secondary myelofibrosis (SMF)\]. * Must have initiated their first treatment on or after the first date when ruxolitinib was approved in their country of residence and no later than 31 December 2021.
    Exclusion Criteria:
    \- Having received MF treatment in a clinical trial setting.

    Protocol Summary

    Myelofibrosis (MF) is a rare blood cancer, characterized by extensive fibrosis (scarring) of the bone marrow. It is one of a group of cancers known as myeloproliferative neoplasms (MPNs) in which bone marrow cells that produce blood cells develop and function abnormally. This study will evaluate treatment patterns, treatment outcomes, healthcare resource utilization in adult participants with Myelofibrosis.

    Data from approximately 1000 participants will be collected. No participants will be enrolled in this study.

    Participants' charts will be reviewed. No drug will be administered as a part of this study. The duration of the observation period is up to 156 weeks.

    There is no additional burden for participants in this trial. All visits must be completed prior to data extraction and participants will be followed for up to 156 weeks.

    Study Locations

    Location
    Status
    Location
    UAB Comprehensive Cancer Center /ID# 252767
    Birmingham, Alabama, United States, 35233-1932
    Status
    Not applicable
    Location
    Wellness Oncology & Hematology /ID# 255591
    West Hills, California, United States, 91307-1468
    Status
    Not applicable
    Location
    Brigham & Women's Hospital /ID# 254312
    Boston, Massachusetts, United States, 02115
    Status
    Not applicable
    Location
    Gabrail Cancer Center Research /ID# 252768
    Canton, Ohio, United States, 44718
    Status
    Not applicable
    Location
    Instituto FIDES /ID# 245526
    La Plata, Buenos Aires, Argentina, 1900
    Status
    Not applicable
    Location
    Hospital Italiano de Buenos Aires /ID# 244373
    Ciudad Autonoma Buenos Aires, Ciuadad Autonoma De Buenos Aires, Argentina, 1199
    Status
    Not applicable
    Showing {first} - {last} of {total} Results